205 related articles for article (PubMed ID: 26939613)
21. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
[TBL] [Abstract][Full Text] [Related]
22. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.
Kasprzak A; Szaflarski W; Szmeja J; Andrzejewska M; Przybyszewska W; Kaczmarek E; Koczorowska M; Kościński T; Zabel M; Drews M
Int J Oncol; 2013 Jan; 42(1):305-16. PubMed ID: 23165777
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms.
Keirsebilck A; Bonné S; Staes K; van Hengel J; Nollet F; Reynolds A; van Roy F
Genomics; 1998 Jun; 50(2):129-46. PubMed ID: 9653641
[TBL] [Abstract][Full Text] [Related]
25. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
Zhang F; Chen JY
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
[TBL] [Abstract][Full Text] [Related]
26. Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma.
Li R; Ochs MF; Ahn SM; Hennessey P; Tan M; Soudry E; Gaykalova DA; Uemura M; Brait M; Shao C; Westra W; Bishop J; Fertig EJ; Califano JA
PLoS One; 2014; 9(3):e91263. PubMed ID: 24675808
[TBL] [Abstract][Full Text] [Related]
27. Multiplexed primer extension sequencing: A targeted RNA-seq method that enables high-precision quantitation of mRNA splicing isoforms and rare pre-mRNA splicing intermediates.
Gildea MA; Dwyer ZW; Pleiss JA
Methods; 2020 Apr; 176():34-45. PubMed ID: 31121301
[TBL] [Abstract][Full Text] [Related]
28. A survey of the complex transcriptome from the highly polyploid sugarcane genome using full-length isoform sequencing and de novo assembly from short read sequencing.
Hoang NV; Furtado A; Mason PJ; Marquardt A; Kasirajan L; Thirugnanasambandam PP; Botha FC; Henry RJ
BMC Genomics; 2017 May; 18(1):395. PubMed ID: 28532419
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.
Papanastasiou AD; Sirinian C; Kalofonos HP
Breast Cancer Res; 2012 Jul; 14(4):R112. PubMed ID: 22824341
[TBL] [Abstract][Full Text] [Related]
30. Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer.
Huang KK; Huang J; Wu JKL; Lee M; Tay ST; Kumar V; Ramnarayanan K; Padmanabhan N; Xu C; Tan ALK; Chan C; Kappei D; Göke J; Tan P
Genome Biol; 2021 Jan; 22(1):44. PubMed ID: 33482911
[TBL] [Abstract][Full Text] [Related]
31. SURVIV for survival analysis of mRNA isoform variation.
Shen S; Wang Y; Wang C; Wu YN; Xing Y
Nat Commun; 2016 Jun; 7():11548. PubMed ID: 27279334
[TBL] [Abstract][Full Text] [Related]
32. Expression of p120-catenin isoforms correlates with genomic and transcriptional phenotype of breast cancer cell lines.
Paredes J; Correia AL; Ribeiro AS; Schmitt F
Cell Oncol; 2007; 29(6):467-76. PubMed ID: 18032823
[TBL] [Abstract][Full Text] [Related]
33. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer.
Yang IS; Son H; Kim S; Kim S
BMC Genomics; 2016 Aug; 17(1):631. PubMed ID: 27519173
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Analysis of Isoform Switching in Cancer.
Dolgalev G; Poverennaya E
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373214
[TBL] [Abstract][Full Text] [Related]
35. Network-based approach to identify principal isoforms among four cancer types.
Ma J; Wang J; Ghoraie LS; Men X; Haibe-Kains B; Dai P
Mol Omics; 2019 Apr; 15(2):117-129. PubMed ID: 30720033
[TBL] [Abstract][Full Text] [Related]
36. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
37. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.
Vu TN; Pramana S; Calza S; Suo C; Lee D; Pawitan Y
Oncotarget; 2016 Oct; 7(42):68851-68863. PubMed ID: 27634900
[TBL] [Abstract][Full Text] [Related]
39. Role of Alternatively Spliced Messenger RNA (mRNA) Isoforms of the Insulin-Like Growth Factor 1 (IGF1) in Selected Human Tumors.
Kasprzak A; Szaflarski W
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977489
[TBL] [Abstract][Full Text] [Related]
40. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma.
Tanaka N; Yoshida H; Suzuki Y; Harigaya K
Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]